• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎、白癜风和斑秃统一治疗方法的趋同路径。

Converging paths toward unified therapeutic approaches in atopic dermatitis, vitiligo, and alopecia areata.

作者信息

Tordjman Lea, Mashoudy Kayla D, Czarnowicki Tali

机构信息

University of Miami Miller School of Medicine, Miami, Fla.

Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Fla.

出版信息

J Allergy Clin Immunol. 2025 Apr 22. doi: 10.1016/j.jaci.2025.04.016.

DOI:10.1016/j.jaci.2025.04.016
PMID:40274075
Abstract

Emerging evidence reveals significant epidemiologic, genetic, and immunologic connections between atopic dermatitis, vitiligo, and alopecia areata, challenging previously established notions of their distinct pathogenic and molecular signatures. Exploring these commonalities not only enhances our understanding of each disease's pathogenesis, but also supports the development of unified treatment strategies for these frequently co-occurring disorders. This review examines key immune players shared across the 3 conditions, including cytokines, immune cells, and signaling pathways. Building on these insights, we also evaluate a range of therapeutic options-ranging from treatments approved by the Food and Drug Administration to those currently in clinical trials-alongside proposed future therapeutic targets. This comprehensive approach aims to advance our management of these interconnected autoimmune and inflammatory disorders with greater precision.

摘要

新出现的证据揭示了特应性皮炎、白癜风和斑秃之间在流行病学、遗传学和免疫学方面的显著联系,挑战了此前关于它们独特致病机制和分子特征的既定观念。探索这些共性不仅能增进我们对每种疾病发病机制的理解,还支持为这些经常同时出现的疾病制定统一的治疗策略。本综述探讨了这三种疾病共有的关键免疫因素,包括细胞因子、免疫细胞和信号通路。基于这些见解,我们还评估了一系列治疗选择,从美国食品药品监督管理局批准的治疗方法到目前正在进行临床试验的方法,以及未来提议的治疗靶点。这种全面的方法旨在更精确地推进我们对这些相互关联的自身免疫性和炎症性疾病的管理。

相似文献

1
Converging paths toward unified therapeutic approaches in atopic dermatitis, vitiligo, and alopecia areata.特应性皮炎、白癜风和斑秃统一治疗方法的趋同路径。
J Allergy Clin Immunol. 2025 Apr 22. doi: 10.1016/j.jaci.2025.04.016.
2
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?白癜风或斑秃患者中恶性黑色素瘤、角质形成细胞癌及其他癌症的发病率、分期和预后:个体内或家族性风险?
Br J Dermatol. 2025 Jun 20;193(1):66-73. doi: 10.1093/bjd/ljaf074.
3
Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.白癜风和斑秃与特应性皮炎的相关性:系统评价和荟萃分析。
JAMA Dermatol. 2015 May;151(5):522-8. doi: 10.1001/jamadermatol.2014.3324.
4
Interventions for alopecia areata.斑秃的干预措施。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD004413. doi: 10.1002/14651858.CD004413.pub2.
5
Topical tacrolimus for atopic dermatitis.外用他克莫司治疗特应性皮炎。
Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2.
6
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。
Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.
7
Specific allergen immunotherapy for the treatment of atopic eczema.特异性变应原免疫疗法治疗特应性皮炎
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008774. doi: 10.1002/14651858.CD008774.pub2.
8
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.斑秃患者眉毛和睫毛受累情况及巴瑞替尼治疗反应的研究
Br J Dermatol. 2025 Apr 3. doi: 10.1093/bjd/ljaf088.
9
Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives.外用芦可替尼在皮肤科的超说明书用药:系统文献综述与当前观点
Exp Dermatol. 2025 Apr;34(4):e70095. doi: 10.1111/exd.70095.
10
Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis.特应性皮炎与自身免疫性疾病风险:一项系统评价和荟萃分析。
Front Immunol. 2025 Jun 12;16:1539997. doi: 10.3389/fimmu.2025.1539997. eCollection 2025.